DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome.
Motomura K, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nakazato Y, Tanaka Y, Pierscianek D, Kim YH, Mariani L, Vital A, Ohgaki H.
Motomura K, et al. Among authors: pierscianek d.
J Neuropathol Exp Neurol. 2012 Aug;71(8):702-7. doi: 10.1097/NEN.0b013e31825f2e5d.
J Neuropathol Exp Neurol. 2012.
PMID: 22805772